Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGO
501
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $47.6M | 0.03% |
1,366,209
+11,487
| +0.8% | +$383K |
|
502
AutoZone
AZO
$50.9B
| $47.4M | 0.03% |
42,052
-81,637
| -66% | -$86M |
|
|
IMMU
503
DELISTED
Immunomedics Inc
IMMU
| $46.8M | 0.03% |
1,320,782
-1,284,788
| -49% | -$37.6M |
|
504
Vishay Intertechnology
VSH
$5.02B
| $46.7M | 0.03% |
3,060,876
+801,397
| +35% | +$12.5M |
|
505
Becton Dickinson
BDX
$45.8B
| $46.7M | 0.03% |
200,170
+114,790
| +134% | +$27.7M |
|
506
Brown-Forman Class B
BF.B
$13.3B
| $46.4M | 0.03% |
728,624
-1,272,287
| -64% | -$81.1M |
|
507
NCR Voyix
VYX
$1.19B
| $46.2M | 0.03% |
4,345,115
-1,303,609
| -23% | -$14.9M |
|
|
FMTX
508
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $46.1M | 0.03% |
+991,045
| New | +$43M |
|
509
Innospec
IOSP
$2.12B
| $46M | 0.03% |
595,672
+59,994
| +11% | +$4.39M |
|
510
First American
FAF
$8.08B
| $46M | 0.03% |
957,581
+136,255
| +17% | +$6.43M |
|
511
Korn Ferry
KFY
$4.26B
| $45.6M | 0.03% |
1,483,662
+130,602
| +10% | +$3.74M |
|
512
UDR
UDR
$12.7B
| $45.5M | 0.03% |
1,216,399
+231,382
| +23% | +$8.64M |
|
|
SAFM
513
DELISTED
Sanderson Farms Inc
SAFM
| $45.4M | 0.03% |
391,399
+151,667
| +63% | +$19.5M |
|
514
Valero Energy
VLO
$88.7B
| $45.2M | 0.03% |
768,891
-893,994
| -54% | -$53.4M |
|
515
Kornit Digital
KRNT
$708M
| $45.2M | 0.03% |
846,161
-122,545
| -13% | -$4.67M |
|
516
Trimble
TRMB
$13.6B
| $45.2M | 0.03% |
1,046,083
-341,980
| -25% | -$12.8M |
|
517
Eaton
ETN
$150B
| $44.9M | 0.03% |
513,236
+361,567
| +238% | +$29.8M |
|
518
Valvoline
VVV
$5.13B
| $44.4M | 0.02% |
2,297,267
-32,621
| -1% | -$554K |
|
519
Warner Music
WMG
$15B
| $44.3M | 0.02% |
+1,500,000
| New | +$46.8M |
|
|
WCN
520
Waste Connections
WCN
$42.7B
| $43.9M | 0.02% |
468,439
-42,099
| -8% | -$3.75M |
|
521
Vistra
VST
$50.1B
| $43.7M | 0.02% |
2,348,213
-251,871
| -10% | -$4.75M |
|
522
Under Armour Class C
UA
$2.97B
| $43.2M | 0.02% |
4,892,069
+4,801,486
| +5,301% | +$40.8M |
|
|
CSII
523
DELISTED
Cardiovascular Systems, Inc.
CSII
| $43.1M | 0.02% |
1,366,724
+12,858
| +0.9% | +$480K |
|
524
CryoPort
CYRX
$765M
| $43M | 0.02% |
1,420,391
+87,213
| +7% | +$1.94M |
|
525
Axsome Therapeutics
AXSM
$12.1B
| $42.9M | 0.02% |
+521,151
| New | +$40.1M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.